Azitra, Inc. (AZTR:NYSEMKT) closed at $0.072 on October 13, 2026, unchanged on the day. The stock trades 93.4% below its 52-week high of $1.09 and 38.0% above its 52-week low of $0.052. Over the past year, it lost 89.6%. Azitra, Inc. is part of the Health Care sector.
In 252 trading sessions since October 17, 2025, AZTR closed higher on 98 days (39%). Its best day was March 20, 2026 (+60.80%) and its worst was October 13, 2026 (-38.98%). The stock moved 10% or more in a single session 24 times. It opened at least 5% above the previous day's high 4 times.
Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library comprised of approximately 1,500 bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its product ATR-12 is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its product ATR-04 is a genetically modified strain of S. epidermidis for treating the papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease.
Find more stocks like AZTR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.